RUNX3 Gene Expression in Tumor NK Cells from Transcriptomic Analysis

A research paper analyzes the role of the RUNX3 transcription factor in natural killer cell activity within lung adenocarcinoma and hepatocellular carcinoma tumors. The study integrates bulk data from The Cancer Genome Atlas with single-cell RNA sequencing analysis of intratumoral NK cells. Author Guofu Lin published the findings in April 2026.

Use Cases

• Correlate RUNX3 expression levels with patient prognosis and survival data from TCGA.
• Analyze RUNX3 enrichment and differential gene expression in intratumoral NK cells from scRNA-seq data.
• Investigate the association between RUNX3 expression and immune cell infiltration scores, particularly for NK and CD8+ T cells.
• Examine pseudotime trajectory data to model RUNX3's role in NK cell differentiation states.
• Validate in vitro findings linking RUNX3 overexpression to NK cell cytotoxicity, chemotaxis, and granzyme B secretion.

Strengths

• Integrates multiple data sources: bulk transcriptomics from TCGA and single-cell RNA-seq analysis.
• Focuses on two specific cancer types: lung adenocarcinoma (LUAD) and hepatocellular carcinoma (LIHC).
• Includes validation from in vitro experiments on NK cell function.

Limitations

• Primary data is a 1.2 MB PDF, not a structured dataset, limiting direct computational analysis.
• Underlying raw sequencing data or processed matrices are not provided with this publication.
• Findings are specific to LUAD and LIHC, limiting generalizability to other cancer types.

Provenance

Source

Figshare, authored by Guofu Lin.

Collection Method

Analysis of public TCGA data and single-cell RNA sequencing, supplemented by in vitro experiments.

Freshness

Last updated in April 2026.